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CLINICAL CASE

CONGENITAL MESOBLASTIC NEPHROMA:
CASE REPORT
NEFROMA MESOBLÁSTICO CONGÉNITO: REPORTE DE CASO
Carolina F. Paz Soldán Mesta1,a, José Luis Apaza León 2,b, Mariela Tello Pezo3,c,
Roxana M. Lipa Chancolla3,d

ABSTRACT
CLINICAL CASE

Congenital mesoblastic nephroma (CMN) is the most frequent renal tumor in newborns and infants. under 3
months. The clinical case of a patient younger (under) than 3 months, with prenatal diagnosis, referred in a
timely manner for evaluation and management of the Institution by the Institution is presented. CMN is a low
incidence tumor. Early diagnosis as well as complete excision of the tumor are predictors of good prognosis,
as in the case of our patient.
Keywords: Congenital mesoblastic nephroma; Renal tumor; Infants. (Source: MeSH NLM).

RESUMEN
El nefroma mesoblástico congénito (NMC), es el tumor renal más frecuente en recién nacidos e infantes
menores de 3 meses. Se presenta el caso clínico de una paciente menor de 3 meses, con diagnóstico prenatal,
referido de manera oportuna para evaluación y manejo de la Institución. El NMC es un tumor de baja
incidencia. El diagnóstico precoz así como la exéresis completa del tumor son predictores de buen
pronóstico, como en el caso de nuestra paciente.
Palabras claves: Nefroma mesoblástico congénito; Tumor renal; Lactantes. (Fuente: DeCS BIREME).
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INTRODUCTION
Congenital mesoblastic nephroma (CMN), also called
fetal renal hamar toma, leiomyomatous or
mesenchymal hamartoma, is a tumor with a good
prognosis, except for the cell line (1). Described for the
rst time by Bolande in 1967, as a tumor diﬀerent from
nephroblastoma due to its histology, treatment and
prognosis (2). It represents 3 to 5% of all renal tumors in
pediatrics (3), more frequently in newborns and infants
under 3 months (2). Local recurrence and metastasis is 5%
in the rst year (4).

CLINICAL CASE
It's the clinical case of a 54-day-old infant, born at term,
with no history, from Ancash. Referred to institution
with diagnosis of right renal mass on prenatal
ultrasound during third trimester. The mother is a
young woman with no signi cant history or harmful
habits.
In the physical evaluation of the patient, a mass was

CLINICAL CASE

palpated on the right ank, neither mobile nor painful.
The origin is probably due to nephrogenic
mesenchymal proliferation(5). The NMC has a survival of
85% at 5 years. Metastasis is more frequently local,
followed by lung, liver, brain, and heart involvement.
Survival after recurrence or with metastasis is 57% at 5
years (6).

The laboratories did not show alterations, nor did he
present any other symptoms. The ultrasound con rmed
a heterogeneous tumor with regular borders in the
upper 1/3 of the right kidney. Figura1a

Figure 1. Imaging study: a) Renal ultrasound: heterogeneous tumor with regular borders in the upper 1/3 of the
right kidney. b) Abdominal CT with contrast: expansive lesion of slightly heterogeneous density,
41mm x 35mm x 36mm.

A computed tomography scan was performed showing

She presented herself to the Institution's Oncology

an expansive lesion of slightly heterogeneous density,

Committee and it was decided to perform a right radical

located in the upper half of the right kidney, measuring

n e p h re c t o my, e x t r a c t i n g t h e p i e c e w i t h o u t
complications, and she was discharged 9 days after

41mm x 35mm x 36mm (DL x DBH x SD). The mass was

surgery. The right kidney, right suprarenal gland and

con ned to the renal parenchyma, reaching the renal

right ureter are received in the pathological anatomy

pelvis with mild pyelic ectasia and scant vascularity

department. The tumor measures 4.2cm x 3.9cm x 3cm,

without signi cant contrast uptake or internal

located in the upper 2/3 of the right kidney, gray-white
in color, brous and myxoid in appearance, without

calci cations in the tumor. The right kidney presents an

necrosis or hemorrhage, representing 50% of the right

anatomical variant with two right renal veins. Figura1b

renal volume.
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a)

b)

c)

d)

a) Kidney with tumor in the upper pole and perirenal fat. b) Neoplasm with thin spindle cells arranged in
intersecting fascicles. c) Presence of islands of cartilaginous tissue, glomeruli and spindle cells.
d) Positive immunohistochemistry for smooth muscle actin.

Figure 2. Pathological study of renal tumor
stromal tumor, and clear cell sarcoma of the kidney,
with a worse prognosis (1). Obstetric ultrasound allows
intrauterine diagnosis (12). While the computerized axial
tomography of the abdomen allows to make the
diagnosis, as well as to diﬀerentiate between the
histological types (5).

CLINICAL CASE

Microscopy revealed CMN, a classic variant, with
in ltration of the renal capsule, perirenal fat, renal
pelvis, and gerota's fascia. The renal vein, renal sinus,
and surgical border of the ureter were free of neoplasia.
Immunohistochemistry reports negative WT-1 and
Desmin, positive actin and vimentin, and Ki-67 of 2%.
Figure 2
The patient did not receive neoadjuvant or adjuvant
chemotherapy and is controlled in an outpatient clinic,
without presenting surgical complications or
recurrence, with survival to the date of more than 3
years.

The initial treatment is surgical, except for those
patients with a high suspicion of cellular histology and
older than 3 months, where chemotherapy is indicated
from the preoperative period (4). Also, when the tumors
are larger, chemotherapy allows a reduction, with less
risk of intraoperative complications (2). Adjuvant

DISCUSSION
Approximately 5% of perinatal tumors arise from the
kidney. CMN is the second most common tumor after
Wilms' tumor during the rst year and is the most
common in the rst 6 months of life(2) as was the case of
the patient with 2 months of life. Unlike those published
by Geramizadeh, with patients aged between 18
months and 11 years (7).
There are 3 histological types: classic (24%), cellular
(66%), and mixed (10%) being the classic one with the
best prognosis( 4 ). Intrauterine manifests with
polyhydramnios and hydrops fetalis, associated with
premature delivery and hypercalcemia (5). The clinical
picture presents as a palpable mass in the ank (31.8%),
hematuria (27.3%), lumbar pain (22.7%), and
hypertension due to increased renin (8) , it may present
pulmonary hypertension and heart failure (9).

chemotherapy is indicated in patients with incomplete
tumor resection or tumor rupture during excision, as
well as in local recurrence and metastasis.
There are 3 histological variants of CMN: classic, cellular,
and mixed. The classic type is characterized by being a
solid and rm tumor with the presence of a capsule and
broblastic cells, with low mitotic activity and abundant
collagen deposition. The cell type with long
hemorrhagic areas with a necrotic component, high
mitotic activity, invasion of peripheral fat and
connective tissue (11). In immunohistochemistry, CMN is
positive for vimentin and smooth tissue actin, negative
for desmin and Cd34(12).
The pathological anatomy of the patient-reported
classic-type histology with tumor-free surgical margins.

It is more frequent in females , diﬀering from the results
found by Pachls, where males predominated (10) . The
diﬀerential diagnosis is with Wilms tumor, metanephric
(8)

Currently, the patient is free of disease, without
recurrence 3 years after surgery. Unlike what was
published by Jehangir, with a recurrence of up to 71%
Pág. 513
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and metastasis of 42% in patients with cell-type

newborns and infants under 3 months. Good

histology, this being a risk factor (13).

prognostic factors allow greater survival. The initial
treatment is surgical, except for patients with risk

Reported poor prognostic factors are age over 3

factors.

months, positive surgical margins, cellular histological
variant, and tumor rupture during excision (14). The

CLINICAL CASE

patient did not present any of these factors.

Comprehensive evaluation, identifying warning signs
and early intervention are factors that will favor survival

CONCLUSIONS

in pediatric patients with solid abdominal tumors,

ECMN is a low-incidence tumor, more frequent in

which is why it is important to know this pathology.
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